CT-721

Modify Date: 2025-08-25 12:13:20

CT-721 Structure
CT-721 structure
Common Name CT-721
CAS Number 1388710-60-8 Molecular Weight 525.04
Density N/A Boiling Point N/A
Molecular Formula C30H29ClN6O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CT-721


CT-721 is a potent and time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM for wild-type Bcr-Abl kinase, and possesses anti-chronic myeloid leukemia (CML) activities[1].

 Names

Name CT-721

 CT-721 Biological Activity

Description CT-721 is a potent and time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM for wild-type Bcr-Abl kinase, and possesses anti-chronic myeloid leukemia (CML) activities[1].
Related Catalog
Target

IC50: 21.3 nM (wild-type Bcr-Abl kinase)[1]

References

[1]. Sun Y, et al. CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent In Vitro and In Vivo Efficacy in the Treatment of Chronic Myeloid Leukemia. J Cancer. 2017 Aug 23;8(14):2774-2784.

 Chemical & Physical Properties

Molecular Formula C30H29ClN6O
Molecular Weight 525.04

 Safety Information

Hazard Codes Xi
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.